Raymond James Financial Services Advisors, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$144.95 - $152.29 $23,047 - $24,214	-159 Reduced 9.6%	1,497 $226,000
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $49,884 - $87,594	-600 Reduced 26.6%	1,656 $241,000
Q1 2022 May 11, 2022	SELL	$110.08 - $142.92 $1,651 - $2,143	-15 Reduced 0.66%	2,256 $267,000
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $18,749 - $27,914	188 Added 9.03%	2,271 $313,000
Q3 2021 Nov 02, 2021	SELL	$98.85 - $138.91 $9,588 - $13,474	-97 Reduced 4.45%	2,083 $289,000
Q2 2021 Aug 11, 2021	BUY	$65.78 - $105.02 $143,400 - $228,943	2,180 New	2,180 $212,000
Q1 2020 Apr 21, 2020	SELL	$27.51 - $57.29 $191,992 - $399,826	-6,979 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $3,432 - $4,842	84 Added 1.22%	6,979 $380,000
Q3 2019 Nov 07, 2019	SELL	$37.38 - $49.47 $3,738 - $4,947	-100 Reduced 1.43%	6,895 $288,000
Q2 2019 Aug 06, 2019	SELL	$39.79 - $67.01 $28,012 - $47,175	-704 Reduced 9.14%	6,995 $306,000
Q1 2019 May 06, 2019	BUY	$34.52 - $53.29 $2,589 - $3,996	75 Added 0.98%	7,699 $396,000
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $8,197 - $10,750	250 Added 3.39%	7,624 $286,000
Q2 2018 Jul 30, 2018	BUY	$23.62 - $42.29 $174,173 - $311,846	7,374 New	7,374 $291,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account